During the past decade, Monter Cancer Center of the North Shore-LIJ Health System conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 37 clinical trials were completed, i.e. on average, 102.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 20 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monter Cancer Center of the North Shore-LIJ Health System" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 19 trials, followed by "Pfizer" with 6 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monter Cancer Center of the North Shore-LIJ Health System" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "GOG Foundation" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Monter Cancer Center of the North Shore-LIJ Health System" are "Leukemia" (10 trials), "Breast Cancer" (7 trials), "Colorectal Cancer" (5 trials), "Acute Lymphoblastic Leukemia" (4 trials) and "Fallopian Tube Cancer" (4 trials). Many other conditions were trialed in "Monter Cancer Center of the North Shore-LIJ Health System" in a lesser frequency.

Most popular intervention types in "Monter Cancer Center of the North Shore-LIJ Health System" are "Drug" (71 trials), "Other" (17 trials), "Biological" (12 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Paclitaxel" (6 trials), "Carboplatin" (5 trials), "Docetaxel" (5 trials) and "Gemcitabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Monter Cancer Center of the North Shore-LIJ Health System" are 69 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Monter Cancer Center of the North Shore-LIJ Health System". undefined are not yet recruiting, 9 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Monter Cancer Center of the North Shore-LIJ Health System, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Monter Cancer Center of the North Shore-LIJ Health System, 9 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".